Effect | Patients | Caregivers | Effect | Patients | Caregivers | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PCS outcome | Beta | t | p | Beta | t | p | PCS outcome | Beta | t | p | Beta | t | p |
Illness perceptions | Â | Â | Â | Â | Â | Â | Illness perceptions | Â | Â | Â | Â | Â | Â |
Total score: | Â | Â | Â | Â | Â | Â | Consequences: | Â | Â | Â | Â | Â | Â |
Actor effect (B-IPQ) | − 0.100 | − 0.941 | 0.350 | 0.067 | 0.636 | 0.527 | Actor effect (B-IPQ) | − 0.341 | − 0.708 | 0.481 | 0.109 | 0.226 | 0.822 |
Partner effect (B-IPQ) | 0.008 | 0.066 | 0.948 | − 0.008 | − 0.067 | 0.947 | Partner effect (B-IPQ) | − 0.339 | − 0.784 | 0.435 | − 0.076 | − 0.177 | 0.860 |
Actor effect (PCS) | 0.070 | 0.431 | 0.668 | 0.171 | 1.056 | 0.294 | Actor effect (PCS) | 0.086 | 0.545 | 0.587 | 0.133 | 0.841 | 0.403 |
Partner effect (PCS) | 0.327 | 2.439 | 0.017* | 0.323 | 2.407 | 0.018* | Partner effect (PCS) | 0.344 | 2.499 | 0.015* | 0.344 | 2.502  | 0.014* |
Timeline: | Â | Â | Â | Â | Â | Â | Personal control: | Â | Â | Â | Â | Â | Â |
Actor effect (B-IPQ) | − 0.004 | −0.014 | 0.989 | − 0.016 | − 0.045 | 0.964 | Actor effect (B-IPQ) | − 1.080 | − 1.912 | 0.059 | 0.634 | 1.123 | 0.265 |
Partner effect (B-IPQ) | 0.272 | 0.622 | 0.536 | 0.410 | 0.940 | 0.350 | Partner effect (B-IPQ) | 0.103 | 0.233 | 0.816 | 0.447 | 1.009 | 0.316 |
Actor effect (PCS) | 0.130 | 0.860 | 0.392 | 0.144 | 0.950 | 0.345 | Actor effect (PCS) | 0.111 | 0.754 | 0.453 | 0.139 | 0.944 | 0.348 |
Partner effect (PCS) | 0.355 | 2.578 | 0.012* | 0.358 | 2.601 | 0.011* | Partner effect (PCS) | 0.355 | 2.684 | 0.009* | 0.317 | 2.403 | 0.019* |
Treatment control: | Â | Â | Â | Â | Â | Â | Identity: | Â | Â | Â | Â | Â | Â |
Actor effect (B-IPQ) | 0.610 | 0.742 | 0.460 | 0.143 | 0.174 | 0.862 | Actor effect (B-IPQ) | − 0.933 | − 1.874 | 0.065 | − 0.534 | − 1.073 | 0.286 |
Partner effect (B-IPQ) | − 0.247 | −0.274 | 0.785 | − 0.059 | − 0.066 | 0.948 | Partner effect (B-IPQ) | 0.076 | 0.145 | 0.885 | 0.125 | 0.238 | 0.813 |
Actor effect (PCS) | 0.123 | 0.807 | 0.422 | 0.140 | 0.920 | 0.360 | Actor effect (PCS) | 0.095 | 0.601 | 0.549 | 0.123 | 0.780 | 0.438 |
Partner effect (PCS) | 0.329 | 2.464 | 0.016* | 0.333 | 2.495 | 0.015* | Partner effect (PCS) | 0.364 | 2.687 | 0.009* | 0.379 | 2.792 | 0.007* |
Illness concern: | Â | Â | Â | Â | Â | Â | Coherence: | Â | Â | Â | Â | Â | Â |
Actor effect (B-IPQ) | 0.282 | 0.722 | 0.473 | −0.750 | − 1.913 | 0.059 | Actor effect (B-IPQ) | − 1.612 | − 2.011 | 0.048* | 0.060 | 0.076 | 0.940 |
Partner effect (B-IPQ) | − 0.241 | − 0.450 | 0.654 | 0.158 | 0.295 | 0.769 | Partner effect (B-IPQ) | − 0.463 | − 0.638 | 0.525 | 0.277 | 0.382 | 0.703 |
Actor effect (PCS) | 0.144 | 0.911 | 0.365 | 0.088 | 0.559 | 0.578 | Actor effect (PCS) | 0.100 | 0.675 | 0.502 | 0.127 | 0.856 | 0.395 |
Partner effect (PCS) | 0.361 | 2.779 | 0.007* | 0.304 | 2.343 | 0.022* | Partner effect (PCS) | 0.306 | 2 .293 | 0.024* | 0.329 | 2.468 | 0.016* |
Emotional response: | |||||||||||||
Actor effect (B-IPQ) | 0.123 | 0.307 | 0.759 | −0.602 | −1.498 | 0.138 |  |  |  |  |  |  |  |
Partner effect (B-IPQ) | −0.116 | − 0.282 | 0.778 | − 0.326 | − 0.794 | 0.429 |  |  |  |  |  |  |  |
Actor effect (PCS) | 0.072 | 0.467 | 0.641 | 0.138 | 0.871 | 0.386 | Â | Â | Â | Â | Â | Â | Â |
Partner effect (PCS) | 0.350 | 2.674 | 0.009* | 0.306 | 2.337 | 0.022* | Â | Â | Â | Â | Â | Â | Â |
Beliefs about CR | Â | Â | Â | Â | Â | Â | Beliefs about CR | Â | Â | Â | Â | Â | Â |
Necessity: | Â | Â | Â | Â | Â | Â | Exercise concern: | Â | Â | Â | Â | Â | Â |
Actor effect (BCR-Q) | − 0.256 | − 0.487 | 0.628 | − 0.197 | −0.375 | 0.709 | Actor effect (BCR-Q) | − 0.174 | − 0.306 | 0.761 | 0.392 | 0.688 | 0.494 |
Partner effect (BCR-Q) | 0.057 | 0.111 | 0.912 | − 0.100 | − 0.195 | 0.845 | Partner effect BCR-Q) | − 0.346 | − 0.584 | 0.561 | − 0.773 | − 1.302 | 0.197 |
Actor effect (PCS) | 0.118 | 0.774 | 0.441 | 0.135 | 0.887 | 0.378 | Actor effect (PCS) | 0.020 | 0.128 | 0.898 | 0.116 | 0.716 | 0.476 |
Partner effect (PCS) | 0.324 | 2.447 | 0.017* | 0.330 | 2.495 | 0.015* | Partner effect (PCS) | 0.286 | 1.974 | 0.052 | 0.370 | 2.551 | 0.013* |
Practical barriers: | Â | Â | Â | Â | Â | Â | Perceived suitability: | Â | Â | Â | Â | Â | Â |
Actor effect (BCR-Q) | −1.295 | −2.156 | 0.034* | − 0.065 | − 0.109 | 0.914 | Actor effect (BCR-Q) | − 0.130 | − 0.212 | 0.833 | − 0.614 | − 0.996 | 0.322 |
Partner effect (BCR-Q) | −0.433 | − 0.558 | 0.578 | 0.873 | 1.124 | 0.264 | Partner effect (BCR-Q) | − 0.020 | − 0.027 | 0.978 | −0.989 | − 1.307 | 0.195 |
Actor effect (PCS) | 0.181 | 1.196 | 0.235 | 0.122 | 0.809 | 0.421 | Actor effect (PCS) | 0.113 | 0.754 | 0.453 | 0.146 | 0.974 | 0.333 |
Partner effect (PCS) | 0.306 | 2.332 | 0.022* | 0.312 | 2.376 | 0.020* | Partner effect (PCS) | 0.263 | 1.945 | 0.055 | 0.303 | 2.238 | 0.028* |